| Financial Year |
March 31 2023 |
| Monetary Funds |
817,363,456.68 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
233,803.47 |
| Accounts Receivable |
863,470,616.17 |
| Advances to Suppliers |
917,058,697.34 |
| Other Receivables |
259,370,852.42 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
664,908,018.77 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
201,203,376.00 |
| Other Current Assets |
192,665,169.39 |
| Total Current Assets |
4,636,642,847.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
338,889,851.95 |
| Long-term Equity Investment |
1,693,165,889.03 |
| Investment Properties |
684,137,323.52 |
| Fixed Assetes |
13,820,442,267.38 |
| Under-construction Projects |
174,891,317.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
113,072,632.57 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,440,381.59 |
| Deferred Income Tax Assets |
369,513,756.59 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
21,992,467,787.52 |
| Total Assets |
26,629,110,635.00 |
| Short-Term Loans |
977,635,631.41 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
2,212,455,085.98 |
| Accounts Received In Advance |
801,908.72 |
| Employee Compensation Payable |
401,051,331.65 |
| Taxes Payable |
93,251,370.64 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,222,642,003.14 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,431,951,398.55 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
6,723,998,744.02 |
| Long-term Loans |
4,433,728,905.95 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
6,144,714.25 |
| Special Payable |
-- |
| Estimatied Liabilities |
49,126,195.26 |
| Deferred Income Tax Liabilities |
626,644,256.55 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
8,840,445,669.86 |
| Total Liabilities |
15,564,444,413.88 |
| Paid-In Capital(Or Share Stock) |
2,146,650,771.00 |
| Capital Surplus |
4,314,081,939.31 |
| Surplus Reserve |
966,396,220.39 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,030,752,822.24 |
| Minority Stockholder's Interest |
30,065,200.70 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,034,601,020.42 |
| Owner's Equity（Stockholder's Equity） |
11,064,666,221.12 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
26,629,110,635.00 |
